252 related articles for article (PubMed ID: 32691149)
21. Electrolytes: Sodium Disorders.
Braun MM; Mahowald M
FP Essent; 2017 Aug; 459():11-20. PubMed ID: 28806046
[TBL] [Abstract][Full Text] [Related]
22. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
[TBL] [Abstract][Full Text] [Related]
23. Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer.
Bilgetekin I; Erturk I; Basal FB; Karacin C; Karadurmus N; Oksuzoglu B; Demirci U
Int Urol Nephrol; 2021 Feb; 53(2):301-307. PubMed ID: 32869173
[TBL] [Abstract][Full Text] [Related]
24. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
[TBL] [Abstract][Full Text] [Related]
25. [Hyponatremia secondary to inappropriate antidiuretic hormone secretion].
Zamboli P; De Nicola L; Minutolo R; Iodice C; Avino D; Mascia S; D'Angiò P; Calabria M; Conte G
G Ital Nefrol; 2008; 25(5):554-61. PubMed ID: 18985840
[TBL] [Abstract][Full Text] [Related]
26. Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.
Yamashita T; Yoshida M; Yamada H; Asano T; Aoki A; Ikoma A; Kusaka I; Kakei M; Ishikawa SE
Intern Med; 2014; 53(8):845-9. PubMed ID: 24739604
[TBL] [Abstract][Full Text] [Related]
27. Hyponatremia in cancer patients.
Platania M; Verzoni E; Vitali M
Tumori; 2015; 101(2):246-8. PubMed ID: 25908038
[TBL] [Abstract][Full Text] [Related]
28. [Hyponatremia : The water-intolerant patient].
Hensen J
Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):440-7. PubMed ID: 22911166
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of hyponatremia in cancer patients.
Castillo JJ; Vincent M; Justice E
Oncologist; 2012; 17(6):756-65. PubMed ID: 22618570
[TBL] [Abstract][Full Text] [Related]
30. Ten pitfalls in the proper management of patients with hyponatremia.
Filippatos TD; Liamis G; Elisaf MS
Postgrad Med; 2016 Jun; 128(5):516-22. PubMed ID: 27153450
[TBL] [Abstract][Full Text] [Related]
31. Uric acid levels with tolvaptan treatment for syndrome of inappropriate antidiuretic hormone secretion.
Nagamine T
Endocrine; 2024 Mar; 83(3):826-827. PubMed ID: 37982946
[No Abstract] [Full Text] [Related]
32. [Etiology, diagnostics and therapy of hyponatremias].
Laczi F
Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
[TBL] [Abstract][Full Text] [Related]
33. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
Estilo A; McCormick L; Rahman M
Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
[TBL] [Abstract][Full Text] [Related]
34. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
Chen S; Zhao JJ; Tong NW; Guo XH; Qiu MC; Yang GY; Liu ZM; Ma JH; Zhang ZW; Gu F
J Clin Pharmacol; 2014 Dec; 54(12):1362-7. PubMed ID: 24906029
[TBL] [Abstract][Full Text] [Related]
35. Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion.
Verbalis JG
Endocrinol Nutr; 2010 May; 57 Suppl 2():30-40. PubMed ID: 21130960
[TBL] [Abstract][Full Text] [Related]
36. [Hyponatraemia in elderly patient - significance, clarification and therapy].
Gosch M
Dtsch Med Wochenschr; 2022 Mar; 147(6):301-305. PubMed ID: 35291034
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
Jamookeeah C; Robinson P; O'Reilly K; Lundberg J; Gisby M; Ländin M; Skov J; Trueman D
BMC Endocr Disord; 2016 May; 16(1):22. PubMed ID: 27184496
[TBL] [Abstract][Full Text] [Related]
38. Hyponatremia in the neurocritical care patient: An approach based on current evidence.
Manzanares W; Aramendi I; Langlois PL; Biestro A
Med Intensiva; 2015 May; 39(4):234-43. PubMed ID: 25593019
[TBL] [Abstract][Full Text] [Related]
39. Syndrome of inappropriate secretion of anti-diuretic hormone due to hypothalamic hamartoma: use of tolvaptan.
Moon RJ; Soliman M; Hoogenboom L; Gilbert RD; Bird-Lieberman G; Singh J; Bockenhauer D; Kumaran A
J Pediatr Endocrinol Metab; 2023 Sep; 36(9):895-899. PubMed ID: 37327191
[TBL] [Abstract][Full Text] [Related]
40. [Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion].
Sánchez Sobrino P; Fernández Catalina P; Lorenzo Solar M; Rego Iraeta A
Med Clin (Barc); 2015 Aug; 145(3):138-9. PubMed ID: 25543222
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
